Cytocare Inc.: The Irvine pharmaceutical and medical...
- Share via
Cytocare Inc.: The Irvine pharmaceutical and medical equipment company posted net income of $148,456, or 3 cents per share, for the second quarter, contrasted with a net loss of $761,793, or a 16 cent loss per share, for the corresponding quarter last year. Revenue dipped slightly, to $2.5 million from $2.6 million. For the 1991 first half, net income totaled $649,990, or 13 cents per share, on revenue of nearly $5 million. The company recorded a net loss of $1.4 million, or a 29-cent loss per share, on revenue of $6.9 million for the first six months of 1990.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.